CytoSorbents Corp (NAS:CTSO)
$ 0.8 0.0092 (1.16%) Market Cap: 43.45 Mil Enterprise Value: 51.95 Mil PE Ratio: 0 PB Ratio: 2.29 GF Score: 56/100

Q3 2020 Cytosorbents Corp Earnings Call Transcript

Nov 04, 2020 / 09:45PM GMT
Release Date Price: $8.39 (-2.67%)
Operator

Good afternoon, and welcome to the CytoSorbents Third Quarter 2020 Financial and Operating Results Conference Call. (Operator Instructions) Please be advised that the call will be recorded at the company's request.

At this time, I would like to turn the call over to our moderator, Jeremy Feffer. Please go ahead.

Jeremy Feffer
LifeSci Advisors, LLC - MD

Thank you, Stacy, and good afternoon. Welcome to CytoSorbents' Third Quarter 2020 Financial and Operating Results Conference Call. Joining me today from the company are Dr. Phillip Chan, Chief Executive Officer; Vincent Capponi, Chief Operating Officer and President; Kathleen Bloch, Chief Financial Officer; Dr. Efthymios Deliargyris, Chief Medical Officer; Dr. Christian Steiner, Senior Vice President of Sales and Marketing and Managing Director of CytoSorbents Europe Gmbh; and Christopher Cramer, Vice President of Business Development.

Before I turn the call over to Dr. Chan, I'd like to remind listeners that during the call, management's prepared remarks may contain forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot